Envista Holdings Corporation Stock
Equities
NVST
US29415F1049
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.36 USD | +2.54% | +6.08% | -19.53% |
Financials (USD)
Sales 2024 * | 2.57B | Sales 2025 * | 2.66B | Capitalization | 3.33B |
---|---|---|---|---|---|
Net income 2024 * | 142M | Net income 2025 * | 191M | EV / Sales 2024 * | 1.46 x |
Net Debt 2024 * | 435M | Net Debt 2025 * | 65.58M | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
24.2
x | P/E ratio 2025 * |
18.1
x | Employees | 12,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.44% |
Latest transcript on Envista Holdings Corporation
1 day | +2.54% | ||
1 week | +6.08% | ||
1 month | -1.97% | ||
3 months | -7.46% | ||
6 months | -19.00% | ||
Current year | -19.53% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Keller
DFI | Director of Finance/CFO | 49 | 18-12-31 |
Andrew Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Suraj Satpathy
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 19-08-31 | |
Daniel Raskas
BRD | Director/Board Member | 57 | 18-12-31 |
Vivek Jain
BRD | Director/Board Member | 52 | 20-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.75% | 8 M€ | -.--% | ||
0.69% | 2 M€ | -.--% | ||
0.34% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 19.36 | +2.54% | 2,873,033 |
24-05-30 | 18.88 | +3.74% | 2,644,665 |
24-05-29 | 18.2 | +0.94% | 3,754,645 |
24-05-28 | 18.03 | -1.21% | 2,840,374 |
24-05-24 | 18.25 | +1.56% | 1,870,915 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.53% | 3.33B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- NVST Stock